XML 104 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Supplementary Insurance Information, for Insurance Companies Disclosure
12 Months Ended
Dec. 31, 2019
Notes  
Supplementary Insurance Information, for Insurance Companies Disclosure

 

 

SCHEDULE III

 

INDEPENDENCE HOLDING COMPANY

 

SUPPLEMENTARY INSURANCE INFORMATION

 

(in thousands)

 

 

 

 

 

FUTURE

 

 

 

 

 

 

 

 

 

 

 

POLICY

 

 

 

INSURANCE

AMORTIZATION

SELLING

 

 

 

 

DEFERRED

BENEFITS,

 

NET

NET

BENEFITS,

OF DEFERRED

GENERAL &

 

NET

 

 

ACQUISITION

LOSSES &

UNEARNED

PREMIUMS

INVESTMENT

CLAIMS &

ACQUISTION

ADMINISTRATIVE

 

PREMIUMS

 

 

COSTS (1)

CLAIMS

PREMIUMS

EARNED

INCOME (2)

RESERVES

COSTS (1)

EXPENSES (3)

 

WRITTEN

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

Specialty Health

$

- 

42,495 

3,110 

177,991 

4,330 

75,539 

- 

110,527 

$

177,438 

Group disability, life,

 

 

 

 

 

 

 

 

 

 

 

   DBL and PFL

 

- 

146,080 

4,000 

160,702 

7,774 

97,335 

- 

49,894 

 

162,972 

Individual life, annuities

 

 

 

 

 

 

 

 

 

 

 

  and other

 

- 

318,236 

172 

48 

1,294 

1.382 

- 

1,720 

 

48 

Medical Stop-Loss

 

- 

147 

- 

- 

6 

(135) 

- 

(163) 

 

- 

Corporate

 

- 

- 

- 

- 

2,239 

- 

- 

13,001 

 

- 

 

$

- 

506,958 

7,282 

338,741 

15,643 

174,121 

- 

174,979 

$

340,458 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

Specialty Health

$

- 

38,154 

3,635 

184,512 

4,386 

60,749 

- 

113,454 

$

184,513 

Group disability, life,

 

 

 

 

 

 

 

 

 

 

 

  DBL and PFL

 

- 

148,012 

1,737 

136,709 

7,029 

82,948 

- 

42,818 

 

135,662 

Individual life, annuities

 

 

 

 

 

 

 

 

 

 

 

  and other

 

- 

324,063 

185 

27 

1,535 

796 

- 

1,572 

 

27 

Medical Stop-Loss

 

- 

431 

- 

- 

39 

(287) 

- 

150 

 

- 

Corporate

 

- 

- 

- 

- 

2,032 

- 

- 

11,034 

 

- 

 

$

- 

510,660 

5,557 

321,248 

15,021 

144,206 

- 

169,028 

$

320,202 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)In 2015, the Company ceded substantially all of its individual life and annuity policy blocks in run-off and as a result, the remaining balance of deferred acquisition costs is not material at December 31, 2019 and 2018 and is included in other assets on the accompanying Consolidated Balance Sheets. Amortization of deferred acquisition costs was $1,036,000 and $982,000 for the years ended December 31, 2019 and 2018, respectively, and is included in selling, general and administrative expenses on the Consolidated Statements of Income for those periods. 

(2)Net investment income is allocated between product lines based on the mean reserve method. 

(3)Where possible, direct operating expenses are specifically identified and charged to product lines. Indirect expenses are allocated based on time studies; however, other acceptable methods of allocation might produce different results.